NTRB 4.98 (+1.43%)
US67092M2089BiotechnologyBiotechnology

Nutriband (NTRB) Stock Highlights

4.98 | +1.43%
2024-11-21 06:07:37
Nutriband Inc is primarily engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the companys lead product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.

Statistics

Range Today
4.8 5.11
Volume Today 12.9K
Range 1 Year
2.22 9.6
Volume 1 Year 8M
Range 3 Year
1.53 10.45
Volume 3 Year 230.75M
Range 10 Year
1.53 10.57
Volume 10 Year 333.74M

Highlights

Market Capitalization 61.69M (small)
Floating Shares 5.05M
Current Price 4.98
Price To Earnings -7.12
Price To Revenue 21.89
Price To Book 7.33
Earnings Per Share -0.78
Payout Ratio 0%

Performance

Latest +1.43%
1 Month -25.89%
3 Months -14.73%
6 Months +11.66%
1 Year +121.33%
3 Years -8.29%
5 Years +5.96%
10 Years +5.96%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.